Variables Patients with TAVR (N = 7078)
Age group (N, [%]) 65–79 2050 (28.96%)
80–89 3915 (55.31%)
≥90 1113 (15.72%)
Female (N, [%]) 3414 (48.23%)
Race (N, [%]) White 6193 (87.50%)
Black 259 (3.66%)
Hispanic 247 (3.49%)
Asian or Pacific Islander 76 (1.07%)
Native American 13 (0.18%)
Other 290 (4.10%)
Insurance (N, [%]) Medicare/Medicaid 6625 (93.60%)
Private 347 (4.90%)
Self-pay 26 (0.37%)
Other 80 (1.13%)
Elective admission (N, [%]) 5381 (76.10%)
Charlson’s Comorbidity Index (Mean±SD) 2.62±1.61
Atrial fibrillation (N, [%]) 3258 (53.97%)
Coronary arterial disease (N, [%]) 5134 (72.53%)
Cerebrovascular disease (N, [%]) 759 (10.72%)
Congestive heart failure (N, [%]) 5254 (74.23%)
Hypertension (N, [%]) 5836 (82.45 %)
Chronic obstructive pulmonary disease (N, [%]) 1958 (27.66 %)
Peripheral arterial disease (N, [%]) 1660 (23.45 %)
Chronic kidney disease (N, [%]) 2683 (37.91%)
Cancer (N, [%]) 1609 (22.73 %)
Diabetes (N, [%]) 2697 (38.10 %)
Liver disease (N, [%]) 253 (3.57 %)
Other valvular disease (N, [%]) 1165 (16.46 %)
Urban area (N, [%]) 5867 (83.33%)
Delirium (N, [%]) 564 (8.0%)
Dementia (N, [%]) 428 (6.1%)
Frailty (N, [%]) 745 (10.5%)